Cargando…
Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
PURPOSE: The authors aim to investigate the altered monocytes subsets distribution in liver cirrhosis (LC) and subsequent hepatocellular carcinoma (HCC) in association with the expression level of plasma Homo sapiens (has)-miR-21-5p and hsa-miR-155-5p. A step toward non-protein coding (nc) RNA preci...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620275/ https://www.ncbi.nlm.nih.gov/pubmed/37639012 http://dx.doi.org/10.1007/s00432-023-05313-w |
_version_ | 1785130172981182464 |
---|---|
author | Hammad, Reham Eldosoky, Mona A. Elmadbouly, Asmaa A. Aglan, Reda Badr AbdelHamid, Sherihan G. Zaky, Samy Ali, Elham Abd El Hakam, Fatma El-Zahraa Mosaad, Alshaimaa M. Abdelmageed, Neamat A. Kotb, Fatma M. Kotb, Hend G. Hady, Ahmed A. Abo-Elkheir, Omaima I. Kujumdshiev, Sandy Sack, Ulrich Lambert, Claude Hamdy, Nadia M. |
author_facet | Hammad, Reham Eldosoky, Mona A. Elmadbouly, Asmaa A. Aglan, Reda Badr AbdelHamid, Sherihan G. Zaky, Samy Ali, Elham Abd El Hakam, Fatma El-Zahraa Mosaad, Alshaimaa M. Abdelmageed, Neamat A. Kotb, Fatma M. Kotb, Hend G. Hady, Ahmed A. Abo-Elkheir, Omaima I. Kujumdshiev, Sandy Sack, Ulrich Lambert, Claude Hamdy, Nadia M. |
author_sort | Hammad, Reham |
collection | PubMed |
description | PURPOSE: The authors aim to investigate the altered monocytes subsets distribution in liver cirrhosis (LC) and subsequent hepatocellular carcinoma (HCC) in association with the expression level of plasma Homo sapiens (has)-miR-21-5p and hsa-miR-155-5p. A step toward non-protein coding (nc) RNA precision medicine based on the immune perturbation manifested as altered monocytes distribution, on top of LC and HCC. METHODS: Seventy-nine patients diagnosed with chronic hepatitis C virus (CHCV) infection with LC were enrolled in the current study. Patients were sub-classified into LC group without HCC (n = 40), LC with HCC (n = 39), and 15 apparently healthy controls. Monocyte subsets frequencies were assessed by flow cytometry. Real-time quantitative PCR was used to measure plasma hsa-miR-21-5p and hsa-miR-155-5p expression. RESULTS: Hsa-miR-21-5p correlated with intermediate monocytes (r = 0.30, p = 0.007), while hsa-miR-155-5p negatively correlated with non-classical monocytes (r = − 0.316, p = 0.005). ROC curve analysis revealed that combining intermediate monocytes frequency and hsa-miR-21 yielded sensitivity = 79.5%, specificity = 75%, and AUC = 0.84. In comparison, AFP yielded a lower sensitivity = 69% and 100% specificity with AUC = 0.85. Logistic regression analysis proved that up-regulation of intermediate monocytes frequency and hsa-miR-21-5p were independent risk factors for LC progression to HCC, after adjustment for co-founders. CONCLUSION: Monocyte subsets differentiation in HCC was linked to hsa-miR-21-5p and hsa-miR-155-5p. Combined up-regulation of intermediate monocytes frequency and hsa-miR-21-5p expression could be considered a sensitive indicator of LC progression to HCC. Circulating intermediate monocytes and hsa-miR-21-5p were independent risk factors for HCC evolution, clinically and in silico proved. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-05313-w. |
format | Online Article Text |
id | pubmed-10620275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-106202752023-11-03 Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma Hammad, Reham Eldosoky, Mona A. Elmadbouly, Asmaa A. Aglan, Reda Badr AbdelHamid, Sherihan G. Zaky, Samy Ali, Elham Abd El Hakam, Fatma El-Zahraa Mosaad, Alshaimaa M. Abdelmageed, Neamat A. Kotb, Fatma M. Kotb, Hend G. Hady, Ahmed A. Abo-Elkheir, Omaima I. Kujumdshiev, Sandy Sack, Ulrich Lambert, Claude Hamdy, Nadia M. J Cancer Res Clin Oncol Research PURPOSE: The authors aim to investigate the altered monocytes subsets distribution in liver cirrhosis (LC) and subsequent hepatocellular carcinoma (HCC) in association with the expression level of plasma Homo sapiens (has)-miR-21-5p and hsa-miR-155-5p. A step toward non-protein coding (nc) RNA precision medicine based on the immune perturbation manifested as altered monocytes distribution, on top of LC and HCC. METHODS: Seventy-nine patients diagnosed with chronic hepatitis C virus (CHCV) infection with LC were enrolled in the current study. Patients were sub-classified into LC group without HCC (n = 40), LC with HCC (n = 39), and 15 apparently healthy controls. Monocyte subsets frequencies were assessed by flow cytometry. Real-time quantitative PCR was used to measure plasma hsa-miR-21-5p and hsa-miR-155-5p expression. RESULTS: Hsa-miR-21-5p correlated with intermediate monocytes (r = 0.30, p = 0.007), while hsa-miR-155-5p negatively correlated with non-classical monocytes (r = − 0.316, p = 0.005). ROC curve analysis revealed that combining intermediate monocytes frequency and hsa-miR-21 yielded sensitivity = 79.5%, specificity = 75%, and AUC = 0.84. In comparison, AFP yielded a lower sensitivity = 69% and 100% specificity with AUC = 0.85. Logistic regression analysis proved that up-regulation of intermediate monocytes frequency and hsa-miR-21-5p were independent risk factors for LC progression to HCC, after adjustment for co-founders. CONCLUSION: Monocyte subsets differentiation in HCC was linked to hsa-miR-21-5p and hsa-miR-155-5p. Combined up-regulation of intermediate monocytes frequency and hsa-miR-21-5p expression could be considered a sensitive indicator of LC progression to HCC. Circulating intermediate monocytes and hsa-miR-21-5p were independent risk factors for HCC evolution, clinically and in silico proved. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-05313-w. Springer Berlin Heidelberg 2023-08-28 2023 /pmc/articles/PMC10620275/ /pubmed/37639012 http://dx.doi.org/10.1007/s00432-023-05313-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Hammad, Reham Eldosoky, Mona A. Elmadbouly, Asmaa A. Aglan, Reda Badr AbdelHamid, Sherihan G. Zaky, Samy Ali, Elham Abd El Hakam, Fatma El-Zahraa Mosaad, Alshaimaa M. Abdelmageed, Neamat A. Kotb, Fatma M. Kotb, Hend G. Hady, Ahmed A. Abo-Elkheir, Omaima I. Kujumdshiev, Sandy Sack, Ulrich Lambert, Claude Hamdy, Nadia M. Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma |
title | Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma |
title_full | Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma |
title_fullStr | Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma |
title_full_unstemmed | Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma |
title_short | Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma |
title_sort | monocytes subsets altered distribution and dysregulated plasma hsa-mir-21-5p and hsa-mir-155-5p in hcv-linked liver cirrhosis progression to hepatocellular carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620275/ https://www.ncbi.nlm.nih.gov/pubmed/37639012 http://dx.doi.org/10.1007/s00432-023-05313-w |
work_keys_str_mv | AT hammadreham monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT eldosokymonaa monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT elmadboulyasmaaa monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT aglanredabadr monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT abdelhamidsherihang monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT zakysamy monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT alielham monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT abdelhakamfatmaelzahraa monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT mosaadalshaimaam monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT abdelmageedneamata monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT kotbfatmam monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT kotbhendg monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT hadyahmeda monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT aboelkheiromaimai monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT kujumdshievsandy monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT sackulrich monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT lambertclaude monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma AT hamdynadiam monocytessubsetsaltereddistributionanddysregulatedplasmahsamir215pandhsamir1555pinhcvlinkedlivercirrhosisprogressiontohepatocellularcarcinoma |